Agency | $2,600,000 | (Aug 29, 2024)
Pryzm | $2,000,000 | (Aug 29, 2024)
Melodi Health | $10,750,000 | (Aug 29, 2024)
Certified by Founder
Lodge
Ancilia Biosciences
start up
United States
- New York, New York
- 29/08/2024
- Unknown
- $4,200,000
Ancilia is harnessing the natural power of CRISPR to develop a new class of bacterial therapies and products for a range of applications.
- Industry Biotechnology
- Website https://www.anciliabio.com/
- LinkedIn https://www.linkedin.com/company/ancilia/
Ampersand Energy | $2,000,000 | (Aug 29, 2024)
Pangeam Inc. | $4,250,000 | (Aug 29, 2024)
Moveo.AI | $2,600,000 | (Aug 29, 2024)
Parry Labs | $80,000,000 | (Aug 29, 2024)
MIRIS | $26,000,000 | (Aug 29, 2024)
OpusClip | $30,000,000 | (Aug 29, 2024)
Inventive AI | $4,000,000 | (Aug 29, 2024)
Piramidal (YC W24) | $6,000,000 | (Aug 29, 2024)